Navigation Links
HOPA Introduces Scope Of Hematology/Oncology Pharmacy Practice
Date:10/22/2013

CHICAGO, Oct. 22, 2013 /PRNewswire-USNewswire/ -- As oncology treatments become more personalized and complex, the role of the hematology/oncology pharmacist has expanded and become more comprehensive.  Recognizing that there is a significant disconnect in how hematology/oncology pharmacists are perceived by the public and, even other healthcare providers, and the crucial contributions they make to the cancer care team, the Hematology/Oncology Pharmacist Association (HOPA) developed a comprehensive document detailing their important role. "As an organization, we are excited to announce the release of this Scope of Hematology/Oncology Pharmacy Practice document. In addition to emphasizing and clarifying the role of hematology/oncology pharmacists, it can be used as a tool to educate health care leaders, the public, and policy makers on the impact these specially trained pharmacists can have in the care of cancer patients," says Niesha Griffith RPh MS FASHP, HOPA president.  

The Scope of Hematology/Oncology Pharmacy Practice is the first document to clearly define the knowledge, skills and functions of the hematology/oncology pharmacist, primarily related to direct patient care, and to promote a better understanding of this ever-growing profession. As a specialty area within pharmacy practice, the oncology pharmacist plays a vital role in treatment selection, management, research, education and even performance improvement.

Because oncology medications are often extremely toxic, require complicated preparation and administration, and are frequently expensive, having a specially trained hematology/oncology pharmacist as a member of the patient care team ensures an enhanced level of care. "Oncology pharmacists are able to improve medication safety, provide supportive care and support in making treatment decisions and ultimately impact a patient's quality of life. We hope that publishing this scope document will foster a more unified approach to data-driven, evidence-based support for the inclusion of oncology pharmacists into all cancer care settings," states Dr. Laura Michaud PharmD BCOP, co-editor. 

The Scope of Hematology Oncology Pharmacy Practice was developed to demonstrate that hematology/oncology pharmacists facilitate and improve patient care through evidence-based treatment selection, medication monitoring and modification, and symptom management.  Hematology/oncology pharmacists are also on the front lines addressing insurance coverage issues, providing patient education and advocating for improved cancer care in the health policy arena.  "Oncology pharmacists are involved in these aspects with individual patients, but are also involved in developing policies and guidelines that can improve patient safety as it relates to medications and their use in a variety of different health care settings. If more pharmacists were involved in these processes, patient care may be improved further," says immediate past president of HOPA and co-editor, Lisa Holle PharmD BCOP. 

A copy of the Scope of Hematology/Oncology Pharmacy Practice can be found here.

HOPA

HOPA is a nonprofit professional organization formed in 2004 to help oncology and hematology pharmacy practitioners and their associates provide the best possible cancer care. HOPA supports research, conducts educational conferences to advance knowledge, encourages professional development and advocates for health policy issues that improve patient care. HOPA has nearly 2000 members and includes oncology pharmacists, as well as pharmacy interns, residents, nurses, technicians, researchers, and administrators specializing in hematology/oncology practice. To learn more about HOPA, visit www.hoparx.org

This news release was issued on behalf of Newswise™. For more information, visit http://www.newswise.com.

Media Contact:
Elizabeth Sherman 847.375.6307
esherman@hoparx.org


'/>"/>
SOURCE Hematology/Oncology Pharmacy Association (HOPA)
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. RF Technologies Introduces New CodeWatch Designs for Wandering Management Solution
2. Elsevier Introduces SimChart for the Medical Office, a Hands-on EHR to Teach Medical Assistant Students Electronic Documentation
3. NxStage Introduces Web-Based Dosing Calculator
4. Elekta Introduces Groundbreaking Image Guidance Capabilities Integrated with Versa HD Cancer Treatment System
5. Flower Orthopedics Introduces New Standards for Delivering Cost-effective Orthopedic Surgery
6. Sciton Introduces Forever Bare BBL For Unprecedented Comfort in Hair Removal
7. Allscripts Introduces Population Health Analytics
8. Apeks introduces fully automated, closed loop CO2 extraction system for Botanical and Essential oil production
9. Quest Diagnostics Introduces Comprehensive Opioid Therapy Genetic Test Based on CYP450 Biomarker License with Transgenomic
10. Innovative BioDefense Introduces Zylast Antiseptic Lotion
11. Gulf Coast Spine Care Introduces New Neck Pain Treatment Options
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... 19, 2017 Shire plc (LSE: ... U.S. Food and Drug Administration (FDA) has acknowledged receipt ... Application (NDA) for SHP465, a long-acting, triple-bead, mixed amphetamine ... once-daily treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA is ... 20, 2017, the designated Prescription Drug User Fee Act ...
(Date:1/19/2017)... 19, 2017 Pfizer joins ... Milner Therapeutics Consortium   Major research ... Cambridge   The Milner Therapeutics ... ) as a partner to the Milner Therapeutics Consortium. ... the efficient transfer of materials between industry and academia ...
(Date:1/19/2017)... Florida , January 19, 2017 ... Trump administration appears serious about reducing the FDA,s ... and innovation in the medical drug industry, many ... ahead with new clinical trials and development of ... companies forging ahead with recent developments include:  Moleculin ...
Breaking Medicine Technology:
(Date:1/22/2017)... TX (PRWEB) , ... January 22, 2017 , ... ... provide slow results. Often the results of a simple test will take days to ... Any Lab Test Now offers customers direct access to their lab tests, bypassing the ...
(Date:1/21/2017)... (PRWEB) , ... January 21, 2017 , ... Phytocéane ... Indian Ocean, isolated from the rest of the world with ZANZIBAR SHOWER GEL. Inspired ... Phytocéane used key ingredients, Virgin Coconut Oil and moisturizing vegetal coral to create this ...
(Date:1/21/2017)... ... January 21, 2017 , ... The Nobel ... Dan Holtzclaw in media for its creos™ line of bone regenerative products. ... Holtzclaw in which he utilizes creos™ allo.gain™ bone graft for a variety of ...
(Date:1/20/2017)... , ... January 20, 2017 , ... Doctor C LLC, ... attended the January ECRM trade show to continue the marketing and distribution of its ... supplement, known for providing 400 percent better absorption than traditional vitamin C supplements. At ...
(Date:1/20/2017)... ... January 20, 2017 , ... Michael and Betsy Brauser celebrated 5 years ... Betsy, the clinical trial has been life-saving as she has been on the ... Betsy Brauser was diagnosed with ovarian cancer in 2009. She underwent standard chemotherapy but ...
Breaking Medicine News(10 mins):